XBI icon

SPDR S&P Biotech ETF

742 hedge funds and large institutions have $8.2B invested in SPDR S&P Biotech ETF in 2022 Q4 according to their latest regulatory filings, with 122 funds opening new positions, 231 increasing their positions, 239 reducing their positions, and 63 closing their positions.

Holders
742
Holders Change
+42
Holders Change %
+6%
% of All Funds
11.97%
Holding in Top 10
31
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-6.06%
% of All Funds
0.5%
New
122
Increased
231
Reduced
239
Closed
63
Calls
$1.66B
Puts
$1.31B
Net Calls
+$351M
Net Calls Change
+$262M
Name Market Value Shares Shares
Change
Shares
Change %
ACA
801
Atlas Capital Advisors
Wyoming
-97 Closed
AWM
802
Aspire Wealth Management
Massachusetts
-71 Closed
ACM
803
Absolute Capital Management
Pennsylvania
-26 Closed
IAMOG
804
Investors Asset Management of Georgia
Georgia
-12 Closed
MAM
805
Meeder Asset Management
Ohio
-8 Closed
OFG
806
Oxford Financial Group
Indiana
-3 Closed
CLOS
807
Compagnie Lombard Odier SCmA
Switzerland
CL
808
CSS LLC
Illinois
Marshall Wace
809
Marshall Wace
United Kingdom
KCM
810
Kingdon Capital Management
New York
CIM
811
Cowen Investment Management
New York
HFS
812
Hantz Financial Services
Michigan
$0 3
GTC
813
Ghost Tree Capital
New York
PL
814
Parkwood LLC
Ohio
PCM
815
Prelude Capital Management
New York
ACM
816
Aquilo Capital Management
California
IC
817
Ikarian Capital
Texas
TSS
818
Two Sigma Securities
New York
SM
819
SG3 Management
Puerto Rico
TM
820
Triatomic Management
California
CAM
821
CenterStar Asset Management
Illinois
AG
822
Artal Group
Luxembourg
Walleye Capital
823
Walleye Capital
New York
BFM
824
Boothbay Fund Management
New York
TI
825
Telemetry Investments
New York